Seasonique Information

What's inside Seasonique

Recent Seasonique Side Effects

Posted by llaurell 9 months ago
I receveid this email today. Date: Wed, 12 Mar 2008 11:24:01 -0400 (EDT) I received this information and thought that...

Posted by rachelmhand 10 months ago
I've took this 5years and didn't notice any side effects other than not getting a period :) recently I quit taking it for 2 m...

Seasonique in the News

ALSO NOTED: Government could force doc disclosures; Barr sues ... - FiercePharma
... filed a patent infringement suit against Watson Pharmaceuticals, alleging it had infringed on its patent for the contraceptive Seasonique. ...
Thu Mar 06 13:04:54 -0500 2008

Watson seeks approval to market generic version of Barr's Seasonique - CNNMoney.com
based Watson said it believes it may be the first to file this type of application for Seasonique, and it may be entitled to 180 days of generic market ...
Tue Mar 04 16:57:10 -0500 2008

Barr Files Suit Against Watson Over Application For Generic ... - Medical News Today (press release)
22 issued a patent for Seasonique, which expires in 2024. That same day, Watson notified Barr that it had filed an FDA abbreviated new drug application to ...
Fri Mar 07 09:02:58 -0500 2008

Seasonique Chemical Information

ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)

levonorgestrel - The levorotatory form of norgestrel and synthetic progestogen with progestational and androgenic activity. Levonorgestrel binds to the progesterone receptor in the nucleus of target cells, thereby stimulating the resulting hormone-receptor complex, initiating transcription, and increasing the synthesis of certain proteins. This results in a suppression of luteinizing hormone (LH) activity and an inhibition of ovulation, as well as an alteration in the cervical mucus and endometrium.